Volume 11.19 | May 18

ESC & iPSC News 11.19 May 18, 2016
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC on Twitter
 
TOP STORY
Inheritance of a Nuclear PIWI from Pluripotent Stem Cells by Somatic Descendants Ensures Differentiation by Silencing Transposons in Planarian
Using Dugesia japonica, the authors showed that a nuclear PIWI, DjPiwiB, was bound to PIWI-interacting RNAs (generally key mediators of PIWI-dependent transposon silencing), and was detected in not only neoblasts but also their descendant somatic cells, which do not express piwi. [Dev Cell] Abstract | Graphical Abstract
Free Sample: TeSR™2 Defined, Feeder-Free and Xeno-Free Human ES and iPS Cell Medium
 
PUBLICATIONS (Ranked by impact factor of the journal)
An Epigenetic Switch Regulates De Novo DNA Methylation at a Subset of Pluripotency Gene Enhancers during Embryonic Stem Cell Differentiation
Scientists investigated the effect of the Lsd1-Mi2/NuRD complex on the dynamic regulatory switch that induces the local interaction of histone tails with the Dnmt3 ATRX-DNMT3-DNMT3L domain, thus promoting DNA methylation at the enhancers of a subset of pluripotency genes. [Nucleic Acids Res] Full Article

Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs
The authors showed that mouse embryonic stem cells (ESCs) depleted of ten-eleven translocation (Tet) 1 and/or Tet2 by RNAi exhibit short telomeres and chromosomal instability, concomitant with reduced telomere recombination. [Cell Rep] Full Article | Graphical Abstract

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy
Investigators developed genome therapy in human myotonic dystrophy type 1 induced pluripotent stem (iPS) cells to eliminate mutant transcripts and reverse the phenotypes for developing autologous stem cell therapy. [Mol Ther] Abstract

Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium
Researchers described a robust and simple method for generating cerebral organoids from human pluripotent stem cells by using a chemically defined hydrogel material and chemically defined culture medium. [Stem Cells Transl Med] Abstract

Generation and Gene Expression Profiling of 48 Transcription-Factor-Inducible Mouse Embryonic Stem Cell Lines
Previously, the authors generated and analyzed 137 transcription factor (TF)-inducible mouse embryonic stem cells (ESCs) lines. As an extension of this “NIA Mouse ESC Bank,” they generated and characterized 48 additional mouse ESC lines, in which single TFs in each line could be induced in a doxycycline-controllable manner. [Sci Rep] Full Article

Derivation of Porcine Embryonic Stem-Like Cells from In Vitro-Produced Blastocyst-Stage Embryos
Investigators described the derivation of porcine embryonic stem-like cells by seeding the isolated inner cell mass from in vitro-produced porcine blastocyst into α-MEM with basic fibroblast growth factor. [Sci Rep] Full Article

Generation and Characterization of Integration-Free Induced Pluripotent Stem Cells from Patients with Autoimmune Disease
Scientists demonstrated the successful generation of integration-free induced pluripotent stem cells from patients with ankylosing spondylitis, Sjögren’s syndrome and systemic lupus erythematosus. [Exp Mol Med] Full Article

Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells
Renal proximal tubule epithelial cells were isolated from multiple sclerosis patients’ urine and transfected with pluripotency-inducing episomal factors. Subsequent induced pluripotent stem cells were formed into embryoid bodies selective for ectodermal lineage, resulting in neural tube-like rosettes and eventually neural progenitor cells. [PLoS One] Full Article

Take the Guesswork Out of Finding the Right Antibody. 25% Off Your First Order With the Purchase of Another Product
 
REVIEWS
Fine-Tuning Next-Generation Genome Editing Tools
The authors compare available methods for detecting, measuring, and analyzing off-target mutations. They particularly focus on CRISPR/Cas9 regarding various methods, tweaks, and software tools available to nullify off-target effects. [Trends Biotechnol] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.
 
INDUSTRY NEWS
Nanologica and Alcyone Lifesciences to Collaborate via Licensing Agreement
Nanologica enters into a license and collaboration agreement with Alcyone Lifesciences to develop Abela – a treatment for motor neuron disorders including amyotrophic lateral sclerosis (ALS). The goal is to develop and commercialize through partnership with biopharma a treatment of certain motor neuron disorders, including ALS, based on targeted and sustained delivery of trophic factors in combination with embryonic stem cell derived cells. [Nanologica] Press Release

Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel™
Cell Therapy Ltd. announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor cells) to Daiichi Sankyo. [Cell Therapy Ltd.] Press Release

From our sponsor: Free wallchart from Nature Neuroscience – Neural Stem Cells. Request your copy.
 
POLICY NEWS
Global Standards for Stem-Cell Research
In response to scientific progress and evolving ethical concerns, the International Society for Stem Cell Research issued updated and extended guidelines for work involving the manipulation of stem cells and the translation of that work into medical therapies. [Nature News] Editorial

‘Brexit’ Would Hit U.K. Research Hard, Report Says
Leaving the European Union would cause a steep drop in research funding for scientists in the United Kingdom, according to a new study—and it’s unclear whether the country can “buy its way back” into European funding schemes under favorable conditions. [ScienceInsider] Editorial
 
EVENTS
NEW From Stem Cells to Human Development
September 25-28, 2016
Southbridge, United States

Visit our events page to see a complete list of events in the ESC & iPSC community.
 
JOB OPPORTUNITIES
NEW Scientific Communications and Publishing Coordinator (STEMCELL Technologies Inc.)

NEW Technical Sales Representative (STEMCELL Technologies Inc.)

NEW Postdoctoral Fellowship – Human Pluripotent Stem Cell Differentiation (Washington University School of Medicine)

Research Technologist – Myogenic and Progenitor Cell (STEMCELL Technologies Inc.)

Scientist – Human Pluripotent Stem Cell Neural Differentiation (STEMCELL Technologies Inc.)

Scientist – Target Validation (Innate Pharma)

Postdoctoral Position – Epigenetics of Aging (Leibniz Institute on Aging)

Postdoctoral Position – Epigenetics and Aging (Leibniz Institute on Aging – Fritz Lipmann Institute)

Scientist and Postdoctoral Positions – Stem Cells (National Institutes of Health)

Postdoctoral Positions – Stem Cell/Genome Editing/Neuroscience/Neurodegeneration (Brigham & Women’s Hospital)

Postdoctoral Researcher – Stem Cell Biology Regenerative Medicine Institute (NUI Galway)


Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about ESC & iPSC News: Archives | Events | Contact Us